Insight Molecular Diagnostics Inc.
IMDX
$3.41
$0.041.19%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 518.00K | 2.14M | 1.49M | 115.00K | 104.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 518.00K | 2.14M | 1.49M | 115.00K | 104.00K |
| Cost of Revenue | 168.00K | 806.00K | 869.00K | 43.00K | 32.00K |
| Gross Profit | 350.00K | 1.33M | 617.00K | 72.00K | 72.00K |
| SG&A Expenses | 4.11M | 4.32M | 3.76M | 3.61M | 3.26M |
| Depreciation & Amortization | -- | 7.00K | 22.00K | 22.00K | 22.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.56M | 7.98M | 6.91M | 6.49M | 5.77M |
| Operating Income | -7.04M | -5.84M | -5.42M | -6.38M | -5.66M |
| Income Before Tax | -9.74M | -6.67M | -33.51M | -13.49M | -4.53M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.74M | -6.67M | -33.51M | -13.49M | -4.53M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.74M | -6.67M | -33.51M | -13.49M | -4.53M |
| EBIT | -7.04M | -5.84M | -5.42M | -6.38M | -5.66M |
| EBITDA | -6.48M | -5.35M | -4.86M | -6.04M | -5.34M |
| EPS Basic | -0.30 | -0.26 | -1.93 | -0.98 | -0.36 |
| Normalized Basic EPS | -0.14 | -0.14 | -0.19 | -0.29 | -0.27 |
| EPS Diluted | -0.30 | -0.26 | -1.93 | -0.98 | -0.36 |
| Normalized Diluted EPS | -0.14 | -0.14 | -0.19 | -0.29 | -0.27 |
| Average Basic Shares Outstanding | 32.02M | 25.69M | 17.38M | 13.71M | 12.87M |
| Average Diluted Shares Outstanding | 32.02M | 25.69M | 17.38M | 13.71M | 12.87M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |